Target intelligence / Profile preview

Respiratory chain flavoenzyme

Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Respiratory chain flavoenzymes are a group of redox-active proteins located within the inner mitochondrial membrane that utilize flavin cofactors, such as flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN), to facilitate electron transfer (UniProt). Key members include NADH dehydrogenase (Complex I) and succinate dehydrogenase (Complex II), which serve as entry points for electrons into the electron transport chain from NADH and succinate, respectively (PubMed: 11016955). These enzymes play a critical role in oxidative phosphorylation, the primary process for cellular ATP production (StatPearls). Dysregulation or genetic mutations in these flavoenzymes are linked to various mitochondrial diseases, neurodegenerative conditions like Parkinson's disease, and metabolic syndromes (PubMed: 10839993). Pharmacologically, these enzymes are often targets for inhibitors like rotenone or metformin, which can modulate metabolic flux or, in the case of toxins, lead to significant cellular damage through the overproduction of reactive oxygen species (PubChem). Because this term refers to a functional class of multiple distinct enzymes rather than a single molecular entity, it is often categorized as a group target in biochemical literature.

Other names
Mitochondrial flavoenzymeFlavin-linked respiratory enzymeRespiratory flavoprotein
02

Mechanism of action

Inhibition of electron transfer within the mitochondrial respiratory chain, leading to decreased ATP production and increased generation of reactive oxygen species (ROS).

03

Biological functions

Electron transport chainOxidative phosphorylationRedox signalingTricarboxylic acid cycleFatty acid oxidation
04

Disease associations

Mitochondrial encephalomyopathyNeurodegenerative diseaseParkinson's diseaseMetabolic disorderCancer
05

Safety considerations

Mitochondrial toxicityLactic acidosisIndication of oxidative stressSystemic metabolic disruption
06

Interacting drugs

Rotenone

5 more in the full profile.

07

Biomarkers

Lactate-to-pyruvate ratioOxygen consumption rate (OCR)Mitochondrial membrane potentialReactive oxygen species (ROS) levels

Beyond the preview

Go deeper on Respiratory chain flavoenzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory chain flavoenzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call